Sign In
Buy MNK
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Mallinckrodt stock soars, after disclosure that $200 million opioid-settlement payment was delayed by a week
01:49pm, Friday, 16'th Jun 2023
Shares of Mallinckrodt PLC MNK, +24.14% shot up 26.5% in afternoon trading, after the drug maker said it reached an agreement to delay a $200 million opioid-settlement payment by a week. The stock's r
Mallinckrodt looking to delay $200 million opioid payment - Bloomberg News
06:35pm, Thursday, 15'th Jun 2023
Mallinckrodt is seeking to postpone a $200 million opioid settlement payment, Bloomberg News reported on Thursday citing people with knowledge of the matter.
Mallinckrodt stock falls after decision not to make interest payments, as drug maker continues to mull potential bankruptcy
07:24am, Thursday, 15'th Jun 2023
Shares of Mallinckrodt PLC MNK dropped 4.8% in premarket trading Thursday, after the drug maker disclosed that it decided not to make interest payments that were due on June 15 on two senior secured n
Why Is Mallinckrodt (MNK) Stock Down 23% Today?
08:32am, Monday, 05'th Jun 2023
Mallinckrodt (NYSEMKT: MNK ) stock is falling hard on Monday after the company received letters from concerned noteholders. These letters have holders of notes due in 2027 and 2029 expressing issues
Mallinckrodt evaluating another possible bankruptcy filing as $200 million opioid settlement pay comes due
07:41am, Monday, 05'th Jun 2023
Shares of Mallinckrodt PLC MNK, -5.41% tumbled 22.0% in premarket trading Monday, after the drug maker disclosed that certain debt holders proposed another bankruptcy filing given the company's financ
Drugmaker Mallinckrodt says lenders propose another bankruptcy filing
07:29am, Monday, 05'th Jun 2023
Drugmaker Mallinckrodt plc said on Monday some of its lenders have proposed that the company consider another bankruptcy filing as it nears a deadline to pay a $200 million opioid settlement.
Drugmaker Mallinckrodt may file for bankruptcy again -WSJ
10:30pm, Friday, 02'nd Jun 2023
Pharmaceutical company Mallinckrodt Plc is considering options including filing for bankruptcy again as a $200 million opioid settlement payment is due within weeks, the Wall Street Journal reported o
Mallinckrodt to Report Earnings Results for First Quarter 2023
06:45am, Monday, 24'th Apr 2023
DUBLIN , April 24, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report first quarter 2023 earnings results for th
Mallinckrodt plc (MNK) Q4 2022 Earnings Call Transcript
10:43am, Tuesday, 28'th Feb 2023
Mallinckrodt plc (NYSE:MNK ) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Daniel Speciale - Global Corporate Controller and Chief Investor Relations Officer Sigur
Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference
08:03am, Thursday, 16'th Feb 2023
DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson, President and Chief Executive Officer,
Mallinckrodt to Report Earnings Results for Fourth Quarter 2022
06:45am, Wednesday, 08'th Feb 2023
DUBLIN , Feb. 8, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report fourth quarter 2022 earnings results for th
Mallinckrodt Will Likely Survive The Opioid Claims And Litigations
12:18am, Friday, 11'th Nov 2022
Mallinckrodt develops and markets specialty pharmaceutical products for autoimmune and rare diseases. In my view, investors really forgot about the potential future free cash flow that Mallinckrodt co
Mallinckrodt plc (MNK) Q3 2022 Earnings Call Transcript
10:50am, Tuesday, 08'th Nov 2022
Mallinckrodt plc (NYSE:MNK ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Daniel Speciale - Global Corporate Controller & Chief IR Officer Sigurdur Olafsson - Pres
Mallinckrodt plc (MNK) CEO Sigurdur Olafsson on Q2 2022 Results - Earnings Call Transcript
12:42pm, Thursday, 11'th Aug 2022
Mallinckrodt plc (NYSE:MNK ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Daniel Speciale - Global Corporate Controller & Chief IR Officer Sigurdur Olafsson - Presi
How To Predict Sales Growth
03:23pm, Tuesday, 08'th Sep 2020
I've found seven factors that correlate highly with future sales growth; this article explains each one.
